NCT03944655View on ClinicalTrials.gov

Does Strepsils® With Lignocaine Lozenges Reduce Post Operative Sore Throat Due To Supraglottic Airway Devices

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Sore ThroatPost Operative Sore Throat
Interventions
DRUG

Strepsils Anaesthetic Formula

Oral administration of a Strepsils® Max Plus lozenge containing the active ingredients amylmetacresol 0.6 mg, 2,4-dichlorobenzyl alcohol 1.2 mg, lignocaine hydrochloride 10mg with sweeteners and flavourings.

DIETARY_SUPPLEMENT

Clear Mint Drops

Oral administration of a lozenge containing glucose syrup, sugar, and flavourings

Trial Locations (1)

50603

University Malaya Medical Centre, Kuala Lumpur

All Listed Sponsors
lead

Dr Sebastian Sundaraj

OTHER

NCT03944655 - Does Strepsils® With Lignocaine Lozenges Reduce Post Operative Sore Throat Due To Supraglottic Airway Devices | Biotech Hunter | Biotech Hunter